The Vitreous Wipe. Clinical evaluation of an investigational medical device.

The Vitreous Wipe. Clinical evaluation of an investigational medical device. - Vitreous wipe.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46076

Enrollment

Registered

2018-08-28

Start date

2019-11-11

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal detachment (or other damage)

Interventions

Removing vitreoschisis with the Vitreous Wipe.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Informed consent. (If vitreoschisis is positively identified intraoperatively, subject agrees with the use of the Vitreous Wipe.) Age * 18 years.

Exclusion criteria

Exclusion criteria: Previous vitrectomy. Tractional retinal detachment. Proliferative retinal vascular disease. Proliferative vitreoretinopathy.

Design outcomes

Primary

Measure	Time frame
Completeness of vitreoschisis removal, as visualised with triamcinolone, intraoperatively.	—

Secondary

Measure	Time frame
Visual outcome, compications.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)